Literature DB >> 6697064

Release of noradrenaline and dopamine by nerve stimulation in the guinea-pig and rat vas deferens.

C Bell, J S Gillespie, I M Macrae.   

Abstract

Spontaneous and nerve stimulated release of noradrenaline and dopamine from rat and guinea-pig vas deferens have been measured electrochemically after separation by high performance liquid chromatography (h.p.l.c.). In the absence of nerve stimulation both noradrenaline (NA) and dopamine were released into the bathing fluid in the rat but in the guinea-pig only noradrenaline could be detected. Drugs which block neuronal and extraneuronal uptake of catecholamines had little effect on spontaneous overflow but both tetraethylammonium and phenoxybenzamine increased overflow. Transmural nerve stimulation (5-10 Hz) increased catecholamine overflow in both species and dopamine release was now measurable from the guinea-pig vas. In the rat, the proportion of dopamine to NA was unchanged from that released spontaneously. The release of both amines was little affected by drugs that block neuronal and extraneuronal uptake and a monoamine oxidase inhibitor, but was inhibited by tetrodotoxin 0.2 microgram ml-1. In the guinea-pig tetraethylammonium 10 mM doubled overflow and phenoxybenzamine 10(-5)M increased it by five times but the dopamine percentage remained constant and equal to the control. Following nerve stimulation the amount of dopamine released expressed as a percentage of total catecholamine release was 6% for the rat and 1.3% for the guinea-pig. These values were considerably higher than the comparable figures for dopamine: NA content of the two tissues (2% and 0.5% respectively). Repeated periods of stimulation depleted these tissue stores and the depletion of dopamine was significantly greater than that of NA. 6 Our interpretation of these results is that both dopamine and NA are released from a common store during normal noradrenergic transmission. While all or most of the axonal dopamine is contained in this releasable pool, most of the axonal NA lies in a second, less readily released pool.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697064      PMCID: PMC1986852          DOI: 10.1111/j.1476-5381.1984.tb10110.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Catecholamines in blood.

Authors:  B A Callingham; M A Barrand
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

Review 2.  Dopamine as a postganglionic autonomic neurotransmitter.

Authors:  C Bell
Journal:  Neuroscience       Date:  1982-01       Impact factor: 3.590

3.  Subcellular distribution and release by sympathetic nerve stimulation of dopamine and alpha-methyl dopamine.

Authors:  J M Musacchio; J E Fischer; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1966-04       Impact factor: 4.030

4.  An electrophysiological analysis of the effects of noradrenaline and alpha-receptor antagonists on neuromuscular transmission in mammalian muscular arteries.

Authors:  M E Holman; A Surprenant
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  Plasma and urinary dopamine: studies during fasting and exercise and in tetraplegic man.

Authors:  N J Christensen; C J Mathias; H L Frankel
Journal:  Eur J Clin Invest       Date:  1976-09-10       Impact factor: 4.686

6.  Effect of handling and forced immobilization on rat plasma levels of epinephrine, norepinephrine, and dopamine-beta-hydroxylase.

Authors:  R Kvetnansky; C L Sun; C R Lake; N Thoa; T Torda; I J Kopin
Journal:  Endocrinology       Date:  1978-11       Impact factor: 4.736

7.  Dopamine and noradrenaline levels in peripheral tissues of several mammalian species.

Authors:  C Bell; J S Gillespie
Journal:  J Neurochem       Date:  1981-02       Impact factor: 5.372

8.  Effects of dopamine on adrenergic neuromuscular transmission in the guinea-pig vas deferens.

Authors:  C Bell
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

  8 in total
  9 in total

1.  Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

2.  Effects of Bay K 8644 on 45Ca uptake and efflux and on contraction in the rabbit aorta.

Authors:  Y J Dong; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

3.  Sympathetic activation: a mechanism for morphine induced pain and rises in liver enzymes after cholecystectomy?

Authors:  I C Roberts-Thomson; J R Jonsson; D B Frewin; G C Coates
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

4.  A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

5.  Pharmacological investigations of the vasodilator nerves supplying the duck's foot.

Authors:  C Bell; A C Rome
Journal:  Br J Pharmacol       Date:  1984-08       Impact factor: 8.739

6.  Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens.

Authors:  J A García-Sevilla; J K Zubieta
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

7.  Calcium modulatory properties of 2,6-dibutylbenzylamine (B25) in rat isolated vas deferens, cardiac and smooth muscle preparations.

Authors:  R Pirisino; G Banchelli; G Ignesti; L Mantelli; R Matucci; L Raimondi; F Buffoni
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Release of 5-hydroxytryptamine, dopamine and noradrenaline in the rat vas deferens in the presence of compound 48/80, veratridine or K+.

Authors:  S M Celuch; B D Sloley
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

9.  Regional distribution of dopamine, 5-hydroxytryptamine, and noradrenaline in the rat vas deferens.

Authors:  S M Celuch; B D Sloley
Journal:  Neurochem Res       Date:  1988-10       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.